Douglas John Karas - 30 Dec 2022 Form 4 Insider Report for Nascent Biotech Inc.

Role
Director
Signature
/s/ Douglas Karas
Issuer symbol
NBIO on OTC
Transactions as of
30 Dec 2022
Net transactions value
+$5,000
Form type
4
Filing time
03 Jan 2023, 14:09:20 UTC
Previous filing
04 Apr 2022
Next filing
09 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $5,000 +25,000 +1.7% $0.2000* 1,486,482 30 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.